SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015236
Filing Date
2023-05-03
Accepted
2023-05-03 16:22:09
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20230331.htm   iXBRL 10-Q 892634
2 EX-10.1 cort33123ex101eighthamendm.htm EX-10.1 34127
3 EX-31.1 cort33123ex311.htm EX-31.1 9773
4 EX-31.2 cort33123ex312.htm EX-31.2 9732
5 EX-32.1 cort33123ex321.htm EX-32.1 5431
6 EX-32.2 cort33123ex322.htm EX-32.2 5357
12 capture.gif GRAPHIC 55192
  Complete submission text file 0001628280-23-015236.txt   4273053

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20230331.xsd EX-101.SCH 31883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20230331_cal.xml EX-101.CAL 60584
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20230331_def.xml EX-101.DEF 97510
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20230331_lab.xml EX-101.LAB 379687
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20230331_pre.xml EX-101.PRE 230495
54 EXTRACTED XBRL INSTANCE DOCUMENT cort-20230331_htm.xml XML 576532
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 23884356
SIC: 2834 Pharmaceutical Preparations